Table 3

Patient-reported outcomes (PPS)

HD203 (n=115)ETN (n=118)
Mean (SD) HAQ
 Baseline1.09 (0.73)1.10 (0.70)
 Week 24 change from baseline−0.49 (0.63)−0.53 (0.59)
 Week 48 change from baseline−0.49 (0.60)−0.53 (0.56)
Mean (SD) SF-36
 Baseline physical component summary31.90 (7.45)32.45 (8.25)
 Baseline mental component summary39.68 (11.47)39.96 (11.81)
Week 24 change from baseline
 Physical component summary8.04 (8.14)7.15 (9.11)
 Mental component summary5.42 (11.54)5.18 (10.28)
 Week 48 change from baseline
 Physical component summary8.50 (8.66)8.54 (8.82)
 Mental component summary5.02 (11.84)4.48 (11.28)
Mean (SD) FACIT-F total
 Baseline mean (SD) FACIT-F total92.24 (22.54)93.67 (26.25)
 Week 24 change from baseline16.43 (21.01)15.61 (20.09)
 Week 48 change from baseline16.86 (22.97)15.00 (22.49)
  • ETN, etanercept; FACIT-F, Functional Assessment of Chronic Illness Therapy-Fatigue scale total score; HAQ, Health Assessment Questionnaire; PPS, per-protocol set; SF-36, Short-Form 36 health survey.